How much has Antiva Biosciences raised?
$144.8Macross 4 recorded rounds · Feb 2017 – Apr 2023
Most recently, Antiva Biosciences raised $38.5M in its Early Stage VC (Apr 2023).
Free account
More of Antiva Biosciences with a free account
- ·The complete investor list: 21 names
- ·Watch Antiva Biosciences: the Monday email on marks, rounds and moves
Antiva Biosciences round by round
4 rounds21 investors participated
20 investors participated
8 investors participated
15 investors participated
How much has Antiva Biosciences raised?
Antiva Biosciences has raised $145 million across 4 recorded rounds since 2017. The largest was a $38.5 million early-stage round in Apr 2023.
Antiva Biosciences has filed 6 Form Ds with the SEC since 2017, most recently in Oct 2024 ($38.5 million sold to 21 investors).
Antiva Biosciences investors
21 investors are on record for Antiva Biosciences, including Mana Ventures, Gaingels, GV and University of California. By type, the record holds 7 venture capital firms. The early-stage round in Apr 2023 drew 21 investors.
For fundraisers
Raising for a company like Antiva Biosciences?
21 investors have backed Antiva Biosciences.
Frequently asked about Antiva Biosciences
- How much has Antiva Biosciences raised?
- Antiva Biosciences has raised $144.8M in total across 4 recorded funding rounds.
- When was Antiva Biosciences's last funding round?
- Antiva Biosciences's most recent recorded round was Early Stage VC in Apr 2023, raising $38.5M.